Using the Collaborative Cross for Model Studies of Intestinal Cancer
使用协作交叉进行肠癌模型研究
基本信息
- 批准号:9308925
- 负责人:
- 金额:$ 14.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:APC geneAddressAdenocarcinomaAdenomatous Polyposis ColiAffectAgeAlcohol consumptionAllelesBloodCarcinoid TumorCatalogsCeliac DiseaseChromosome MappingColonColon CarcinomaColorectalColorectal CancerComplexCongenic StrainCoupledCrohn&aposs diseaseCystic FibrosisDNADevelopmentDiagnosisDietDiffuseDiseaseEndocrineEpstein-Barr Virus InfectionsExhibitsFamily history ofFemaleFutureGastrointestinal NeoplasmsGastrointestinal PolypGastrointestinal tract structureGenderGenesGeneticGenetic VariationGenetic studyGenomicsGoalsGrowthHealthHealth StatusHelicobacter pyloriHereditary Nonpolyposis Colorectal NeoplasmsHumanHybridsImmuneInbreedingIndividualInheritedIntestinal CancerIntestinesInvestigationLaboratoriesLeadLettersLi-Fraumeni SyndromeLifeLocationLymphomaMalignant NeoplasmsMalignant neoplasm of gastrointestinal tractMapsMeasuresModelingMolecularMusMutateMutationNeoplasm MetastasisObesityOne-Step dentin bonding systemOrganPartner in relationshipPathologistPatientsPersonsPhenotypePolypsPredispositionPreventive therapyProbabilityRadiation exposureRecombinantsRectal CancerRectumRefractoryReproducibilityResearchResistanceResolutionResourcesRiskRisk FactorsRunningSex ChromosomesSmall Intestinal AdenocarcinomaSmall IntestinesStomachStromal NeoplasmStudy modelsSyndromeSystems BiologyTeenagersTissuesTobacco useTumor TissueVariantWomanadenomaattributable mortalityautosomecancer riskdesigndisease phenotypegenetic variantgenomic variationhuman diseasein vivoindexinginnovationlifetime riskmalemalignant small intestine tumormalignant stomach neoplasmmenmitochondrial genomemortalitymouse modelmutantnoveloffspringpolyposisprecision medicinepreventprogenitorstomach surgerytraittumortumorigenesis
项目摘要
Using the Collaborative Cross for Model Studies of Intestinal Cancer
Gastrointestinal (GI) cancers are worldwide health issues that are both highly prevalent and deadly. The ability
to understand the genetic factors influencing the change of normal stomach, small intestine, and colorectal
tissues towards the initiation, growth and progression to cancer is essential to the goals of precision medicine.
As with every cancer, being able to identify people at risk before the cancer appears provides the greatest
opportunity to intervene and prevent the development of life-threatening disease. To better model human
disease, the Collaborative Cross (CC) was generated and has captured the tremendous genomic variation
present within one mammalian species, the mouse. The CC are recombinant inbred (RI) lines created from
the genomic contributions of 8 inbred founder strains, chosen because of their evolutionary diversity with each
other. The unique combination of alleles within the different CC lines facilitates: 1) the identification of disease
phenotypes more extreme than have been observed in common inbred laboratory strains, and 2) the
opportunity for high resolution mapping of loci influencing complex traits. Our studies represent an avenue to
investigate, characterize, and quantitate GI tumor phenotypes within individual CC lines. We propose to use a
sensitized background, namely a mutation in the adenomatous polyposis coli (Apc) gene coupled with a
resistant Mom2R allele, and mate these mice with the CC lines in a one-step cross to screen for dominant
modifiers that lead to increased tumorigenesis or altered tumor profiles. We have incorporated a mutant Apc
allele because the APC gene is one of the top 5 genes mutated in stomach, small intestine, and colorectal
cancers in humans. The use of the CC lines coupled with the use of our unique, long-lived, but sensitized
congenic strain brings an innovative approach to the in vivo study of GI cancers.
利用协作交叉进行肠癌模型研究
胃肠道(GI)癌症是世界范围内的健康问题,既高度流行又致命。的能力
了解影响正常胃、小肠、结直肠改变的遗传因素
组织对癌症的发生、生长和发展的影响对于精准医学的目标至关重要。
与每一种癌症一样,能够在癌症出现之前识别出有风险的人,
有机会干预和预防危及生命的疾病的发展。为了更好地模拟人类
疾病,协作交叉(CC)的产生,并已捕获了巨大的基因组变异
存在于一种哺乳动物物种--小鼠中。CC是由以下产生的重组近交(RI)系:
8个近交创始菌株的基因组贡献,选择这些菌株是因为它们之间的进化多样性
其他.不同CC系内等位基因的独特组合促进:1)疾病的鉴定
表型比在普通近交实验室品系中观察到的更极端,和2)
为影响复杂性状的基因座的高分辨率定位提供了机会。我们的研究代表了一种途径,
研究、表征和定量个体CC系中的GI肿瘤表型。我们建议使用
致敏背景,即腺瘤性结肠息肉病(Apc)基因突变,
抗性Mom 2 R等位基因,并将这些小鼠与CC系在一步杂交中交配以筛选显性Mom 2 R等位基因。
导致肿瘤发生增加或肿瘤特征改变的修饰剂。我们已经整合了一种变异的APC
因为APC基因是胃、小肠和结肠直肠中突变最多的5个基因之一,
人类的癌症使用的CC线加上使用我们独特的,寿命长,但敏感
同类菌株为胃肠道癌的体内研究带来了一种创新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Linda D Siracusa其他文献
Linda D Siracusa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Linda D Siracusa', 18)}}的其他基金
Using the Collaborative Cross for Model Studies of Intestinal Cancer
使用协作交叉进行肠癌模型研究
- 批准号:
9179477 - 财政年份:2016
- 资助金额:
$ 14.91万 - 项目类别:
Use of Closely Related Inbred Strains to Identify Modifier Loci of Tumorigenesis
使用密切相关的近交株来鉴定肿瘤发生的修饰位点
- 批准号:
8507660 - 财政年份:2012
- 资助金额:
$ 14.91万 - 项目类别:
Use of Closely Related Inbred Strains to Identify Modifier Loci of Tumorigenesis
使用密切相关的近交株来鉴定肿瘤发生的修饰位点
- 批准号:
8356584 - 财政年份:2012
- 资助金额:
$ 14.91万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 14.91万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 14.91万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 14.91万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 14.91万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 14.91万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 14.91万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 14.91万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 14.91万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 14.91万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 14.91万 - 项目类别:
Research Grant














{{item.name}}会员




